期刊文献+

硒结合蛋白在膀胱癌中的表达及临床意义

Expression and clinical role of Selenium binding protein 1 in bladder tumor
原文传递
导出
摘要 目的 探讨硒结合蛋白-1(Selenium binding protein 1,SBP1)在不同膀胱组织中的表达情况及其临床意义.方法 运用Western blot法检测膀胱癌组织、膀胱黏膜良性病变组织及正常膀胱黏膜组织中的SBP1的表达,并分析其表达差异性.结果 SBP1在膀胱癌组织中的表达明显低于膀胱黏膜良性病变组织及正常膀胱黏膜(P<0.05),且浅表性膀胱癌组织表达阳性率高于浸润性膀胱癌,无淋巴结转移的膀胱癌组织表达阳性率高于具有淋巴结转移的膀胱癌组织.结论 SBP1在膀胱癌组织中表达下调,膀胱癌的发生、进展可能与SBP1的表达抑制有关. Objectives To investigate the expression of Selenium binding protein 1 (SBP1) in bladder tumor and its clinical significance.Methods 30 bladder cancer tissue and 20 bladder benign lesions and 8 bladder normal tissue were collected to detect the expression of SBP1 by Western blot.Results The expression of the SBP1 in bladder cancer tissue was down-regulated compared with that in bladder benign lesions and bladder normal tissue (0.325 ± 0.065vs0.578 ± 0.073vs0.749 ± 0.052), P 〈 0.05, and the expression of SBP1 in the bladder neoplasms was higher than that in the invasive bladder cancer (0.548 ± 0.082vs0.361 ± 0.048), P 〈 0.05.Moreover, the expression of SBP1 in lymphatic metastasis of bladder cancer was lower than that in no-lymphatic metastasis (0.241 ± 0.047vs0.409 ± 0.058), P 〈 0.05.Conclusions SBP1 is down-regulated in bladder cancer and it is strongly related with the bladder progression, which means that it is probably play an important role in tumorigenesis.
出处 《国际泌尿系统杂志》 2016年第1期71-73,共3页 International Journal of Urology and Nephrology
关键词 硒结合蛋白质类/代谢 膀胱肿瘤/代谢 Selenium-Binding Proteins/ME Urinary Bladder Neoplasms/ME
  • 相关文献

参考文献13

  • 1Chang PW , Tsui SK, Liew C, et al. Isolation, characterization, and chromosomal mapping of a novel eDNA clone encoding human selenium binding protein [J] . J Cell Biochem, 1997 ,64 ( 2 ) : 217 - 224.
  • 2Kim H, Kang HJ, You KT, et al. Suppression of human selenium binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival [J]. Proteomics, 2006 ,6 ( 11 ) : 3466 -3476.
  • 3Zhang J , Zhan N , Dong WG. Altered expression of selenium - bind- ing protein 1 in gastric carcinoma and precursor lesions [J] . Med Oneol ,2011 ,28 (4) :951 - 957.
  • 4Zhang C, Wang YE, Zhang P, et al. Progressive loss of selenium binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low - grade serous carcinoma[J]. Hum Pathol ,2010 ,41 (2) :255 -261.
  • 5Silvers AL, Lin L, Bass AJ, et al. Decreased selenium binding protein 1 in esophageal adenoearcinoma results from posttmnscriptional and epigenetic regulation and affects chemosensitivity [J]. Clin CancerRes,2010,16(7) :2009 -2021.
  • 6Xia Yj, Ma YY , He XJ, et al. Suppression of selenium - binding protein 1 in gastric cancer is associated with poor survival [J] . Hum Pathol,2011 ,42( 11) : 1620 -1628.
  • 7Giusti L, Iaeeoni P, Da Valle Y , et al. A proteomie profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer[J]. Mol Biosyst,2012,8(4) :1088 -1099.
  • 8Jerome? Morais A, Wright ME, Liu R, et al. Inverse association between glutathione pernxidase activity and both Selenium - Binding Protein 1 levels and Gleason score in human prostate tissue [J] . Prostate,2012,72(9) :1006 -1012.
  • 9Zhang J,Dong WG,Lin J. Reduced selenium - binding protein 1 is associated with poor survival rate in gastric carcinoma [J]. Med Oncol,2011 ,28(2) :481 -487.
  • 10Jeong JY, Wang Y, Sytkowski AJ. Human selenium binding protein - 1 (hSP56) interacts with VDUl in a selenium - dependent manner[J]. Biochem Biophys Res Commun,2009 ,379 (2) :583 -588.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部